trending Market Intelligence /marketintelligence/en/news-insights/trending/xsmixhrqy-ftb3dypgozfw2 content esgSubNav
In This List

Xtant Medical issues equity in exchange for debt

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Xtant Medical issues equity in exchange for debt

Xtant Medical Holdings Inc. exchanged about $70.2 million worth of debt for shares in the company.

As part of the previously announced restructuring agreement, the company issued 10,401,309 common shares at $7.20 apiece to ROS Acquisition Offshore LP and OrbiMed Royalty Opportunities II LP who held the company's 6% senior unsecured notes due 2021.

The Belgrade, Mont.-based regenerative medicine developer also closed a private placement of 945,819 common shares, priced at $7.20 each, to ROS and OrbiMed — raising $6.8 million.